
Theravance Biopharma, Inc.
USD17.06
-0.57 (-3.23%)
CEO
Rick E. Winningham
IPO Date
2014-05-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$16.97
Prev. Close
$17.63
Day Low
$16.97
Day High
$17.16
52W Low
$10.82
52W High
$21.03
Market Cap
$0.88B
Volume
3.10M
| 5 Mar 2026 |
| Oppenheimer |
| Outperform |
| Perform |
| downgrade |
| 4 Mar 2026 | B. Riley Securities | Buy | Neutral | downgrade |
| 4 Mar 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 3 Mar 2026 | BTIG | Buy | Buy | maintain |
| 2 Mar 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 3 Feb 2026 | BTIG | Buy | Buy | maintain |
| 26 Nov 2025 | BTIG | Buy | Buy | maintain |